Search results
Results From The WOW.Com Content Network
The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, commonly called the Beers List, [1] are guidelines published by the American Geriatrics Society (AGS) for healthcare professionals to help improve the safety of prescribing medications for adults 65 years and older in all except palliative settings.
Nitrofurantoin, sold under the brand name Macrobid among others, is an antibacterial medication of the nitrofuran class used to treat urinary tract infections (UTIs), although it is not as effective for kidney infections. [16] It is taken by mouth. [16] Common side effects include nausea, loss of appetite, diarrhea, and headaches. [16]
Mark Howard Beers (April 24, 1954 – February 28, 2009) [1] was an American geriatrician whose research on drug interactions among the elderly led to the creation of the eponymous Beers criteria, which lists prescription medications that may have deleterious side effects in older patients.
The Beers Criteria and the STOPP/START criteria help identify medications that have the highest risk of adverse drug events (ADE) and drug-drug interactions. [ 60 ] [ 61 ] [ 62 ] The Medication appropriateness tool for comorbid health conditions during dementia (MATCH-D) is the only tool available specifically for people with dementia, and also ...
Think of this creamy skillet casserole as a one-pan taco. The corn tortillas crisp up under the broiler, adding crunch to go with the creamy filling.
This category contains those articles about the side effects of medications. Some side effects are not adverse. For example, the anti-depressant Welbutrin helps some to quit smoking. Other beneficial side effects of medications can be weight loss. A side effect of insulin is that it removes potassium ions from the blood stream and into cells.
Last year, close to 26,000 students took the exam with just over 4,000 offered a seat. Of that, 4.5% of offers went to Black students and 7.6% to Latino students, according to city data.
Health officials in Europe are investigating Ozempic and the trendy drug’s possible link to an eye-rotting condition that causes blindness. On Dec. 17, the European Medicines Agency announced ...